icap m&e master slide deck data through december 31, 2011

ICAP M&E MASTER SLIDE DECK

DATA THROUGH DECEMBER 31, 2011

2

CONTENTS

Site Census Slide 3

Care and Treatment Indicators Slide 6

PMTCT Indicators Slide 51

Indicators for TB Screening in HIV Care Settings Slide 61

Indicators for HIV Testing in TB Patients Slide 69

Indicators for HIV Testing and Counseling Slide 74

Indicators for Clinical Laboratories Slide 87

SITE CENSUS• What: Ongoing, real-time inventory of all planned, current, and closed ICAP facilities. Supported activities, funding source(s) and their targets are also captured

• Purpose: To have one up to date master list of facilities, activities, funding sources, and targets that all ICAP staff can refer to for planning and evaluation

NUMBER OF SELECTED ACTIVITIES AT SUPPORTED FACILITIES,

AS OF DECEMBER 31, 2011

Num

ber o

f fac

ilitie

s

Source: ICAP Site Census, February 2011Note: Some facilities offer more than one activity.

Total distinct facilities

Care & treatment

TB screening for HIV pts

HIV testing for TB pts

PMTCT Early infant diagnosis

PICT/VCT Lab0

500

1,000

1,500

2,000

2,500

3,000

2706

1003 938

592

2104

1252

1,010

500

Num

ber o

f fac

ilitie

s

NUMBER OF FACILITIES BY COUNTRY, AS OF DECEMBER 31, 2011

Source: ICAP Site Census, February 2011

Kenya Tanzania Ethiopia Mozambique

Lesotho Cote d'Ivoire

South Africa

Swaziland Nigeria DR Congo Rwanda0

100

200

300

400

500

600

700

800

900

1000977

772

277

188127 112 99

64 59 256

Num

ber o

f fac

ilitie

sNUMBER OF FACILITIES EVER SUPPORTED BY ICAP AND TRANSITIONED AS OF SEPTEMBER

2011

Source: Source: ICAP Site Census, February 2011Notes: In transition: A facility may be partially supported by an NGO or MOH but ICAP is still the prime for support and reports directly to Atlanta under MCAP. Completed transition: ICAP is no longer the prime and there is a new mechanism for supporting the site and reporting to USG (e.g., NGO, MOH or another partner).

Overall Cote d'Ivoire DR Congo Ethiopia Kenya Lesotho Mozambique Nigeria Rwanda South Africa Swaziland Tanzania0

500

1,000

1,500

2,000

2,500

3,000

3,500

Active Transitioned Unknown

CARE AND TREATMENT INDICATORS

PROGRAM AND FACILITY CHARACTERISTICS TRACKING

SYSTEM (PFACTS)What: Collects program and facility information

on ICAP-supported care and treatment programs annually

Purpose: To describe the scope, diversity, and comprehensiveness of ICAP-supported care and treatment programs, and evaluate multi-level factors that influence program performance and patient-level outcomes

Perc

ent o

f clin

ics

Source: ICAP PFaCTS Round 6, February 2011. Note: Clinics for which location and site type are not available are excluded. Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas.

HIV CARE AND TREATMENT CLINICS: GEOGRAPHIC LOCATION AND TYPE OF

FACILITY (n=796)

Urban 145

Semi-urban258

Rural393

0%

50%

100%

42% 47%68%

32%38%

13%12%14% 14% 19%

Public primary Public secondary Public tertiary Private/Other

Perc

ent o

f clin

ics

Source: ICAP PFaCTS Round 6, February 2011. Note: Clinics for which location and site type are not available are excluded. Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas.

GEOGRAPHIC LOCATION OF HIV CARE AND TREATMENT FACILITIES, BY COUNTRY

Overall n=796

Cote d'Ivoire

n=63

DR Congo

n=17

Ethiopia n=75

Kenya n=221

Mozambique

n=64

Nigeria

n=42

Rwanda

n=48

South Africa

n=80

Swaziland

n=59

Tanzania

n=127

0%

50%

100%

18%32%

82%

39%

1%

55%

19%29%

21%

7%1%

32%

59%

18%

39%

19%

16%

62%

6%

48%

15%

49%

49%

10%23%

80%

30%19%

65%

31%

78%

50%

Urban Semi-urban Rural

Perc

ent w

ith s

ervic

esPROPORTION OF HIV CARE AND TREATMENT

CLINICS* OFFERING OTHER HIV-RELATED SERVICES (n=789)

Source: ICAP PFaCTS Round 6, February 2011. Note: *“Facility” refers to the larger institution, while “clinic” refers to the unit where care and treatment is provided. **PICT is available at one or more points of service in the facility.

VCT PICT** PMTCT in ANC TB treatment75%

80%

85%

90%

95%

100%

95%

99%

94%

84%

PROPORTION OF HIV CARE AND TREATMENT CLINICS OFFERING PATIENT SUPPORT

SERVICES (n=789)

Perc

ent w

ith s

ervic

e

Source: ICAP PFaCTS Round 6, February 2011.Notes: Facilities with missing data are excluded. ART adherence counseling: Verbal patient education provided by trained personnel at least every 3 months. Outreach: patients who miss clinic follow-up or medication pick up visits are identified and contacted by facility personnel. Nutritional treatment or support for children/infants: provision of nutritional supplements or weaning foods. Nutritional treatment for adults: provision of nutritional supplements or therapeutic foods, e.g. Plumpy’Nut. Food rations: provision of rations, e.g. snacks or food packets to promote ART adherence or household food security.

ART adherence counseling

Outreach for missed visits

Peer educator program

Nutritional treatment for

children and in-fants

Nutritional treatment for

adults

Food rations for adults or chil-

dren

0%

50%

100% 95% 91%

77%

51%

40%

24%

Source: ICAP PFaCTS Round 6, February 2011.Note: Laboratory services offered: Within the facility: specimen collection and testing done within this facility.At another facility: specimen collection done within this facility and testing conducted at another facility or both specimen collection and testing are conducted at another facility.

AVAILABILITY OF LABORATORY ASSAYS AT FACILITIES (n=796)

Perc

ent o

f fac

ilitie

s

CD4 count Hemoglobin / Hematocrit

Creatinine Hepatitis B sur-face antigen

Liver enzyme test

Infant diagnosis / PCR

Sputum smear for TB

HIV-RNA0%

50%

100%

23%

69%

30% 27% 30%

2%

65%

2%

77%

31%

70% 73% 70%

93%

34%

62%

5% 1%

37%

Available within the facility Available at another facility Not available

MEAN NUMBER OF FULL-TIME HEALTH CARE PROVIDERS AT HIV CARE AND TREATMENT

CLINICS (n=782)

Mea

n nu

mbe

r of p

rovid

ers

Source: ICAP PFaCTS Round 6, February 2011.

Overall Nigeria Mozambique

DR Congo South Africa

Ethiopia Cote d'Ivoire

Swaziland Rwanda Kenya Tanzania0.0

2.0

4.0

6.0

8.0

10.0

12.0

0.61.6 1.5 1.4

0.5 0.61.2

0.4 0.4

1.6

4.1

1.5

3.1

3.3

1.71.5

2.0 1.5

0.9 0.7

0.9

4.3

2.70.4

0.1

0.0 0.1

1.10.6

Physicians NursesHealth Officers / Medical Assistants

MEAN NUMBER OF OUTREACH WORKERS AT ICAP-SUPPORTED

HIV CARE AND TREATMENT CLINICS WITH OUTREACH PROGRAMS (n=649*)

Mea

n nu

mbe

r of o

utre

ach

work

ers

Source: ICAP PFaCTS Round 6, February 2011.Note: *Only facilities with outreach programs

Overall South Africa

Mozambique

Nigeria Côte d'Ivoire

Kenya Ethiopia DR Congo Rwanda Swaziland Tanzania0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

1.3

3.63.4

2.0

1.4

0.9

0.7 0.6 0.5 0.5

0.2

PROPORTION OF HIV CARE AND TREATMENT CLINICS OFFERING PATIENT SUPPORT

SERVICES OVER TIME (n=431*)

Source: ICAP PFaCTS Round 6, February 2011. Notes: *Only clinics that submitted all three rounds of data collection are included. ART adherence counseling: Verbal patient education provided by trained personnel at least every 3 months. Outreach: patients who miss clinic follow-up or medication pick up visits are identified and contacted by facility personnel.

0%

50%

100% 97%

69%63%

32%

49%

98%92%

83%

55%

72%

96% 98%

88%

50%

72%

Round 4 Round 5 Round 6

Perc

ent w

ith S

ervi

ce

Overall South Africa Ethiopia Rwanda Tanzania DR Congo Kenya Swaziland Nigeria Côte d'Ivoire

0%

50%

100%

49%

93% 93%

65%

38%

12%

67%

20%

14%

71%

96% 96% 94% 92%

82%

72%68%

55%

22%

ART initiation

Follow-up

Source: ICAP PFaCTS Round 6, February 2011.

PROPORTION OF HIV CARE AND TREATMENT CLINICS

WHERE NURSES PRESCRIBE ARVS, BY TYPE OF VISIT (n=790)

Perc

ent o

f clin

ics

CARE AND TREATMENT QUARTERLY AGGREGATE M&E

INDICATORSWhat: Collects information from ICAP-supported

clinics on a quarterly basis.

Purpose: To describe quarterly and cumulative progress towards targets and overall achievements. 43 collected indicators include care enrollment, ART initiation and enrollment, regimen information, and ART CD4 cohort information.

HIV CARE AND TREATMENT SERVICES AT FACILITIES, AS OF DECEMBER 31, 2011

Source: ICAP URS February 2012.Note: Closed facilities includes facilities that have transitioned to MoH, a local NGO, or another implementing partner. Closed facilities also include clinics previously supported through the MTCT+ Initiative.

Countries Facilities Ever enrolled in HIV care

Ever initiating ART

At current facilities

10 757 1,018,204 499,195

At current and closed facilities

15 992 1,403,939 708,689

CARE AND TREATMENT CLINICS REPORTINGAS OF DECEMBER 31, 2011

Source: ICAP URS February 2012.

Country Facilities supported Facilities reporting

Côte d’Ivoire 65 65

DR Congo 13 5

Ethiopia 275 69

Kenya 284 282

Mozambique 66 66

Nigeria 8 5

Rwanda 5 5

South Africa 96 77

Swaziland 64 56

Tanzania 127 127

TOTAL 1003 757 (75%)

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Sep-08

Dec-08

Mar-09

Jun-09

Sep-09

Dec-09

Mar-10

Jun-10

Sep-10

Dec-10

Mar-11

Jun-11

Sep-11

Dec-11

0

10,000

20,000

30,000

40,000

50,000

60,000

70,000

0

100

200

300

400

500

600

700

800

New care enrollment New ART initiation Care and treatment clinics currently reporting

NEW ENROLLMENT IN HIV CARE AND TREATMENT, BY QUARTER

Source: ICAP URS February 2012.Note: New enrollment includes adults and children. New on treatment include patients who transfer in already on ART. Data are only from clinics currently supported and reporting. The country arrows depict when the country began contributing data.

Num

ber o

f new

pat

ient

s

30,889 initiating ART

58,200 enrolling in

care

757clinics

Number of clinics

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Sep-08

Dec-08

Mar-09

Jun-09

Sep-09

Dec-09

Mar-10

Jun-10

Sep-10

Dec-10

Mar-11

Jun-11

Sep-11

Dec-11

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

0

100

HIV Care ART

CUMULATIVE ENROLLMENT IN HIV CARE AND TREATMENT

Source: ICAP URS February 2012.Notes: Data are only from clinics supported and reporting. The country arrowss depict when the country began contributing data.

Num

ber o

f pat

ient

s Number of clinics

499,194 on ART

1,018,204 in care

757clinics

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Sep-08

Dec-08

Mar-09

Jun-09

Sep-09

Dec-09

Mar-10

Jun-10

Sep-10

Dec-10

Mar-11

Jun-11

Sep-11

Dec-11

0

10,000

20,000

30,000

40,000

50,000

60,000

70,000

80,000

90,000

100,000

0

100

200

300

400

500

600

700

800

HIV care ARTCare and treatment clinics currently reporting

45,107 on ART

CUMULATIVE PEDIATRIC ENROLLMENT IN HIV CARE AND TREATMENT

Source: ICAP URS February 2012.Note: Includes adults and children. Data are only from clinics currently supported and reporting. The country boxes depict when the country began contributing data.

Num

ber o

f pat

ient

s Number of clinics

89,899in care

757clinics

Sep-04

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Sep-08

Dec-08

Mar-09

Jun-09

Sep-09

Dec-09

Mar-10

Jun-10

Sep-10

Dec-10

Mar-11

Jun-11

Sep-11

Dec-11

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

CUMULATIVE ENROLLMENT IN HIV CARE, BY COUNTRY

(n= 1,018,435)

South Africa

Lesotho

Kenya

Tanzania

Rwanda

Nigeria

Num

ber o

f pat

ient

s

DRC

Source: ICAP URS February 2012.Notes: Data is only from care and treatment clinics supported by ICAP and reporting.

Côte d’Ivoire

Ethiopia

Mozambique

Swaziland

38596

38961

39326

39692

40057

40422

40787

0

20,000

40,000

60,000

80,000

100,000

120,000

Mozambique

South Africa

Ethiopia

Kenya

Tanzania

Rwanda

Nigeria

Swaziland

Num

ber o

f pat

ient

sCUMULATIVE ENROLLMENT ON ART, BY

COUNTRY (n=534,124)

Côte d’Ivoire

Source: ICAP URS February 2012.Notes: Data are only from clinics supported and reporting.

Dec-04

Mar-05

Jun-05

Sep-05

Dec-05

Mar-06

Jun-06

Sep-06

Dec-06

Mar-07

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Sep-08

Dec-08

Mar-09

Jun-09

Sep-09

Dec-09

Mar-10

Jun-10

Sep-10

Dec-10

Mar-11

Jun-11

Sep-11

Dec-11

0

100,000

200,000

300,000

400,000

500,000

600,000

ART patients currently retained in HIV care*

CUMULATIVE PATIENTS INITIATED ON ART AND THEIR CURRENT STATUS,

AS OF DECEMBER 31, 2011 (n= 499,195)

Num

ber o

f pat

ient

s

Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting. Data include patients who have temporarily stopped ART for clinical reasons, but are continuing in HIV care.

Cumulative ever initiating ART

Reported dead

Lost to follow-up

De Ju De Ju De Ju De Ju De Ju De Ju De Ju De0

200,000

400,000

600,000

800,000

1,000,000

1,200,000


100,000

200,000

300,000

400,000

500,000

600,000Total care enrollment (n= 1,018,204 ) Total ART enrollment (n= 499,195 )

CUMULATIVE ENROLLMENT IN HIV CARE AND TREATMENT PROGRAMS, BY ART STATUS,

AGE, AND SEX

Men 15+

Women 15+

Children <15Children <15

Men 15+

Women 15+

Source: ICAP URS February 2012Notes: Data is only from care and treatment clinics supported and reporting.

61%

30%

9%

59%

32%

9%

CUMULATIVE ART INITIATION BY SEX AT ICAP-SUPPORTED FACILITIES IN 10 SUB-SAHARAN

AFRICAN COUNTRIES

Women (n= 316,706) Men (n= 182,489)

Source: ICAP URS February 2012Notes: Data is only from care and treatment clinics supported by ICAP and reporting.

Num

ber o

f pat

ient

s


50,000

100,000

150,000

200,000

250,000

300,000

350,000


50,000

100,000

150,000

200,000

250,000

300,000

350,000

Source: URS February 2011Notes: Data are only from clinics currently supported and reporting.

PROPORTION OF ALL PATIENTS EVER ENROLLED IN HIV CARE WHO EVER

INITIATED ART, AS OF DECEMBER 31, 2011

Perc

ent o

f pat

ient

s

Overall n=1018204

DR Congo n=3074

Rwanda n=3184

Ethiopia n=114333

South Africa n=101591

Cote d'Ivoire n=15137

Tanzania n=81488

Swaziland n=73558

Nigeria n=8042

Kenya n=260672

Mozambique

n=357125

0%

50%

100%

49%

86%

63% 61% 60% 58% 56%53% 51% 50%

38%

PROPORTION OF ALL PATIENTS EVER ENROLLED IN HIV CARE,

BY ART STATUS, AGE AND SEX, AS OF DECEMBER 31, 2011

Perc

ent o

f pa

tient

s

Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting.

Pre-ART n=501435

ART n= 499195

Overall n=1018204

0%

50%

100%

63% 59% 61%

29% 32% 30%

8% 9% 9%

Women 15+ Men 15+ Children <15

CUMULATIVE ENROLLMENT IN CARE, BY COUNTRY, AGE, AND SEX, AS OF DECEMBER

31, 2011

Perc

ent o

f pat

ient

s

Source: ICAP URS February 2012Note: Data are only from clinics currently supported and reporting.

Overall n=499195

Cote d'Ivoire

n=8791


Nigeria n=4116

Tanzania n=45345

Kenya n=130773

Swaziland n=38749

Mozam-bique n=135639

DR Congo n=2651

Ethiopia n=70050

Rwanda n=2014

0%

50%

100%

59%66% 64% 63% 59% 59% 59% 58% 56% 53% 53%

32%28% 31% 33%

32% 29% 32% 33%26%

39%

18%

9% 5% 6% 4% 8% 12% 10% 9%17%

8%

28%


Perc

ent o

f pat

ient

sCUMULATIVE ART INITIATION, BY COUNTRY,

AGE, AND SEX, AS OF DECEMBER 31, 2011

Source: ICAP URS February 2012Note: Data are only from clinics currently supported and reporting.

Overall n=1018204

Cote d'Ivoire

n=15137

South Africa

n=101591

Nigeria n=8042

Tanzania n=81488

Kenya n=260672

Mozam-bique

n=357125

Swaziland n=73558

Ethiopia n=114333

Rwanda n=3184

DR Congo n=3074

0%

50%

100%

61%70% 66% 63% 62% 61% 61% 59% 55% 55% 54%

30%26% 30%

29% 31% 28% 31%29% 36%

20% 25%

9% 5% 5% 8% 7% 11% 8% 12% 8%

25%21%


De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De Ma Ju Se De0%

5%

10%

0.4%1.0%

1.5%

3.2%

4.5%

7.2%6.7%

4.7%

PREGNANT WOMEN AS A PROPORTION OF ALL WOMEN INITIATING ART

Source: ICAP URS February 2012

By Country, October-December 2011

Over Time

Perc

ent o

f wo

men

Perc

ent o

f wom

en


DR Congo n=1496

Ethiopia n=37333

Kenya n=77390

Mozambique n=79277

Nigeria n=2592

Rwanda n=1071


Swaziland n=22760

Tanzania n=26965

0%

10%

7%

3%2%

5%

7%

1%

9%

5%

0%

4%

Perc

ent o

f pe

diat

ric p

atie

nts

CUMULATIVE PEDIATRIC HIV CARE ENROLLMENT,

AS OF DECEMBER 31, 2011


Overall

n=89937

Swaziland n=9081

Mozambique n=29352

Cote d'Ivoire

n=714

DR Congo n=692

Tanzania n=5984

Kenya

n=28321

Rwanda n=802

Ethiopia

n=9446

South Africa

n=4931

Nigeria n=614

0%

50%

100%

30%

44% 43%33%

28% 26% 21% 17% 17% 14%2%

25%

20% 22%

27%36%

26%29%

19%30%

21%

3%

42%33%

26%40% 38%

48% 50%

64%53%

66%

95%

0-1 year 2-4 years 5-14 years unknown

CUMULATIVE PEDIATRIC ART ENROLLMENT, AS OF DECEMBER 31, 2011

Perc

ent p

edia

tric

patie

nts

on A

RT


Overall

n=45129

Cote d'Ivoire n=466

Mozam-bique n=11984

Tanzania

n=3651

DR Congo n=477

Rwanda n=572

Ethiopia

n=5356

Kenya n=15189

South Africa n=3510

Nigeria n=169

Swaziland n=3755

0%

50%

100%

21%35% 35%

22% 19% 18% 18% 16% 13% 8%

27%

25% 24%

24% 34%

21% 26% 28%22%

78%

50%

40%31% 54% 46%

61% 56% 56%68%

10%

2%11%

2%4%

0-1 year 2-4 years 5-14 years unknown

ART INITIATION AMONG PATIENTS ELIGIBLE FOR ART IN ICAP-SUPPORTED PROGRAMS,

OCTOBER-DECEMBER 2011

Perc

ent p

atie

nts

elig

ible

for A

RT

Source: ICAP URS February 2012Note: Eligible, but not started: Number in HIV care during the quarter and eligible for ART but NOT started ART by the end of the quarter. Eligible, started: All those who were eligible and started on ART during the reporting quarter.

Overall n=23933

Tanzania n=2232

Kenya n=6485

Ethiopia n=2070

Mozambique n=6864

DR Congo n=251

South Africa n=3689

Cote d'Ivoire n=583

Nigeria n=235

Rwanda n=64

Swaziland n=1460

0%

50%

100%

9%16% 15%

9% 7% 5%

91%84% 85%

91% 93% 95% 98% 100% 100% 100% 100%

% eligible, not started ART % eligible, started ART

REGIMENS USED BY CURRENT ART PATIENTS, OCTOBER-DECEMBER 2011

Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting.

Overall (Adults)n = 260,123

Overall (Children)n = 27,220

1st line regimen 238,091 (92%) 23,560 (87%)

d4T-3TC-NVP 57,821 (22%) 7,226 (27%)

d4T-3TC-EFV 30,836 (12%) 2,175 (8.0%)

ZDV-3TC-NVP 91,008 (35%) 7,892 (29%)

ZDV-3TC-EFV 14,103 (5.4%) 1,190 (4.4%)

Other 44,323 (17%) 5,077 (19%)

2nd line regimen 1,547 (0.6%) 323 (1.2%)

Unknown regimen 20,485 (7.9%) 3,337 (12%)

REGIMENS USED BY CURRENT ADULT ART PATIENTS BY COUNTRY,


Source: ICAP URS February 2012Notes: * In South Africa, D4T-3TC-LPV/r , ZDV-ddl-LPV/r , and ABC-ddl-LPV/r are prescribed as a first-line regimen for pediatric patients. ^ Nigeria only reports regimen information for newly enrolled patients on ART. Data are only from clinics currently supported and reporting.

Côte d'Ivoire Ethiopia Kenya Mozambique Nigeria^ Rwanda South Africa*

Swaziland Tanzania

n=5,828 n=37,893 n=76,091 n=65,777 n=3,923 n=1,173 n=46,212 n= 35,841 n=23,226

1st line regimen

5,757 37,243 75,244 63,895 150 1,125 33,312 0 21,365

(99%) (98%) (99%) (97%) (3.8%) (96%) (72%) 0.0%) (92%)

2nd line regimen

16 431 548 237 1 30 166 0 118

(0.3%) (1.1%) (0.7%) (0.4%) (0.0%) (2.6%) (0.4%) (0.0%) (0.5%)

Unknown55 219 299 1,645 3,772 18 12,734 35,841 1,743

(0.9%) (0.6%) (0.4%) (2.5%) (96%) (1.5%) (28%) (100%) (7.5%)

REGIMENS USED BY CURRENT PEDIATRIC ART PATIENTS BY COUNTRY,


Source: ICAP URS February 2012Notes: ^ Nigeria only reports regimen information for newly enrolled patients on ART. Data are only from clinics currently supported and reporting.

Côte d'Ivoire Ethiopia Kenya Mozambique Nigeria^ Rwanda South Africa Swaziland Tanzania

n=340 n=3,503 n=10,315 n=7,207 n=167 n=315 n=3,171 n=3,128 n=2,202

1st line regimen

326 3,382 9,616 5,388 17 297 2,392 0 2,142

(96%) (97%) (93%) (75%) (10%) (94%) (75%) (0.0%) (97%)

2nd line regimen

12 54 190 15 0 8 22 0 22

(3.5%) (1.5%) (1.8%) (0.2%) (0.0%) (2.5%) (0.7%) (0.0%) (1.0%)

Unknown2 67 509 1,804 150 10 757 3,128 38

(0.6%) (1.9%) (4.9%) (25%) (90%) (3.2%) (24%) (100%) (1.7%)

PROPORTION OF PATIENTS WITH CD4 COUNT AT

BASELINE, 6, AND 12 MONTHS AFTER ART INITIATION

(SUBSET OF ART PATIENTS*)

Perc

ent o

f pa

tient

s

Source: ICAP URS February 2012Notes: *Data only included for patients who were followed for 12 months. Data are only from clinics currently supported and reporting.

Overall n=203191

Rwanda n=803


Ethiopia n=47839


Kenya n=37324

Mozambique n=69933

Tanzania n=24570

0%

50%

100%

77%

99% 97%93% 92%

80%

65% 63%

39%

83%

58%

51% 51% 50%

25%

31%

42%

84%

50% 48%

42%

51%

33%37%

Baseline 6-month 12-month

MEDIAN CD4 COUNT AT BASELINE*, 6, AND 12 MONTHS AFTER ART INITIATION (SUBSET OF

ART PATIENTS**)

CD4

Cell C

ount

(cel

ls/ul

)

Source: ICAP URS February 2012Notes: Average of median CD4 counts at baseline and 6 and 12 months follow up are presented. * Baseline data is average of matched 6 and 12 month cohort data at baseline. ** Data only included for patients who were followed for 12 months.Data are only from clinics currently supported and reporting.

Overall n=5519

Rwanda n=613

Mozambique n=683

Lesotho n=120

Nigeria n=325

Kenya n=1143

Cote d'Ivoire n=342

South Africa n=423

Ethiopia n=825

Tanzania n=1045

0

50

100

150

200

250

300

350

400

450

150

238

174 172 169

138 135 131 130 117

263

362

330310

288255

235

262248

184

297

397

353339 347

298

254

301

275

211

Baseline 6-month 12-month

CHANGE IN MEDIAN CD4 COUNT AFTER 6 AND 12 MONTHS OF ART (SUBSET OF ART

PATIENTS*)

Chan

ge in

med

ian

CD4

coun

t (ce

lls/µ

L)

Source: ICAP URS February 2012Notes: Change in average of median CD4 counts at baseline and 6 and12 months follow up are presented. *Data only included for patients who were followed for 12 months. Data are only from clinics currently supported and reporting.

Overall Mozambique Lesotho South Africa Rwanda Ethiopia Kenya Nigeria Cote d'Ivoire Tanzania0

20

40

60

80

100

120

140

160

180

200

113

157

137 131124

118 117

105100

147

180

167 170159

145

159

178

119

6-month 12-month

Continued ART* 496,544; 83%

Discontinued ART 84,511; 17%

1%

32%

66%

7% per year on

ART

STATUS OF ART PATIENTS, AS OF DECEMBER 31, 2011

(n= 496,544)

.14% per year on

ART

Lost to follow-up

Reported dead

Stopped ART

Source: ICAP URS February 2012Notes: *Includes patients who transferred out while on ART. Data are only from clinics currently supported and reporting.

Rates

3.5% per year on

ART

REASONS FOR ART DISCONTINUATION IN ICAP-SUPPORTED HIV CLINICS, AS OF

DECEMBER 31, 2011

Perc

ent o

f disc

ontin

uing

pat

ient

s

Source: ICAP URS February 2012Notes: Excludes patients who transferred out while on ART.

Overall n=75712

Mozambique n=31294

South Africa n=3143

Kenya n=23364

Nigeria n=15

Ethiopia n=15934

Tanzania n=8799


Rwanda n=149

0%

50%

100%

68% 71% 70% 70% 67% 65%50%

39% 35%

30% 28% 27% 29% 33% 34%

48%

52%49%

1% 1%1% 1% 2%

9%16%

Lost to follow-up Reported dead Stopped ART

PMTCT INDICATORS

PMTCTQUARTERLY AGGREGATE M&E

INDICATORSWhat: Collects information from ICAP-supported

facilities on a quarterly basis

Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 32 indicators covering the counseling, testing, HIV results, and ultimately, the treatment of HIV positive pregnant women and their exposed infants.

PMTCT FACILITIES REPORTINGAS OF DECEMBER 31, 2011




DRC 4 0

Ethiopia 85 83

Kenya 976 891

Mozambique 176 174

Nigeria 59 36

Rwanda 1 1

South Africa 95 87

Swaziland 22 0

Tanzania 587 587

TOTAL 2104 1954 (93%)

Jun-07

Sep-07

Dec-07

Mar-08

Jun-08

Sep-08

Dec-08

Mar-09

Jun-09

Sep-09

Dec-09

Mar-10

Jun-10

Sep-10

Dec-10

Mar-11

Jun-11

Sep-11

Dec-11

0

50,000

100,000

150,000

200,000

250,000

0

500

1000

1500

2000

2500

ANC visit Tested Number of facilities

NUMBER OF PREGNANT WOMEN ATTENDING ANC AND RECEIVING HIV TESTING, JUNE

2007 – SEPTEMBER 2011

Source: ICAP URS February 2012. The country arrows depict when the country started contributing data.

1,954 clinics

164,008 HIV tests

202,656 ANC visits

Num

ber o

f wom

enNum

ber of clinics

S. Africa

Côte d’Ivoire

Mozambique, Rwanda,Ethiopia,Nigeria,

Tanzania

Kenya

Perc

ent o

f wom

enTYPE OF ART REGIMEN FOR PMTCT, BY

COUNTRY, OCTOBER-DECEMBER 2011

Source: ICAP URS February 2012.Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks.

Overall n=8605

Cote d'Ivoire n=253

Ethiopia n=267

Mozambique n=5132

Nigeria n=66

Rwanda n=14

South Africa n=1999

Tanzania n=874

0%

50%

100%

12%20%

0%

66%83%

22%

70%

47%

29%

53%

82%

15%17%

7%

10%

21%

29%

18%7%

72%

53% 50%

18%

SD-NVP Multi-drug regimens Newly initiating ART Already on ART

TYPE OF ART REGIMEN FOR PMTCT, BY QUARTER

Perc

ent o

f wom

en

Source: ICAP URS February 2012Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks.

Sep-08 Dec-08 Mar-09 Jun-09 Sep-09 Dec-09 Mar-10 Jun-10 Sep-10 Dec-10 Mar-11 Jun-11 Sep-11 Dec-110%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

47%37%

26% 28%19% 17%

23%13% 10% 4% 8% 7% 8% 12%

49%57%

67% 65%72% 71%

64%74% 78%

80%81%

70% 68% 66%

5% 6% 7% 7% 9% 12% 12% 12% 12% 16% 11%16% 16% 15%

SD-NVP Multi-drug regimens Initiated ART

Perc

ent

PROPORTION OF HIV+ WOMEN WITH DOCUMENTED CD4 TEST RESULTS IN

CLINICS OFFERING CD4 TESTING 90% target for sites reporting CD4


Cote d'Ivoire Mozambique Nigeria Rwanda South Africa Tanzania0%

20%

40%

60%

80%

100%

Mean January 2010 - December 2011 Oct-Dec 2011% of sites reporting CD4

ART ELIGIBILITY AND INITIATION OF ART AMONG

HIV+ PREGNANT WOMEN

Num

ber o

f wom

en

Source: ICAP URS February 2012Notes: Data is not available for all indicators in all countries.

Mozambique Kenya South Africa Tanzania Cote d'Ivoire Nigeria Ethiopia0

1,000

2,000

3,000

4,000

5,000

6,000

# HIV+

# assessed through clinical staging or CD4 testing

# enrolled in C&T

# eligible for ART

# newly initiating ART

HIV EXPOSED INFANTS, OCTOBER-DECEMBER 2011

Source: ICAP URS February 2012Notes: Data is not available for all indicators in all countries. HIV exposed infants includes women who tested positive in ANC and those who tested positive in maternity during the quarter.

Series10

2,000

4,000

6,000

8,000

10,000

12,000

14,000 13,255

6,465

4,937 4,465

65 139

HIV Exposed Infants

# received prophylaxis

# received CTX

# HEI PCR tested < 2 mos.

PCR tested HIV+

# infants intitiating ART

Indicators for TB Screening in HIV Care

SettingsWhat: Collects information from ICAP-supported facilities on a quarterly basis

Purpose: To describe quarterly and cumulative progress towards targets and overall achievements, through 12 collected indicators.

TB SCREENING IN HIV CARE SETTINGSAS OF DECEMBER 31, 2011


Country Clinics supported Clinics reporting


DR Congo 9 .

Ethiopia 85 67

Lesotho 127 .

Kenya 296 283

Mozambique 61 61

Nigeria 8 6

Rwanda 5 5

South Africa 95 87

Swaziland 60 .

Tanzania 127 127

TOTAL 938 694 (74%)

PROPORTION OF NEW HIV CARE PATIENTS SCREENED FOR TB,


Perc

ent o

f pat

ient

s

Source: ICAP URS February 2012Notes: Data are only from clinics currently supported and reporting. New HIV care patients excludes patients who knew their TB status.

New HIV care patients Overall

n=37433Tanzania

n=3531Rwanda

n=117South Africa

n=8219Kenya

n=9339Cote d'Ivoire

n=1096Mozambique n=14687

Nigeria n=444

0%

50%

100%

75%

100% 99%

89% 88%

74%

55%

26%

PROPORTION OF NEW HIV CARE PATIENTS SCREENED FOR TB,

BY QUARTER

Perc

ent o

f pat

ient

s

Source: ICAP URS February 2012Note: Côte d’Ivoire began reporting in April-June 2008 quarter and South Africa began in July-September 2008 quarter. Data are only from clinics currently supported and reporting. As of March 2010, new HIV care patients excludes patients who knew their TB status at enrollment.

Number of clinics

New HIV care patients with

unknown status

Dec-07 Mar-08 Jun-08 Sep-08 Dec-08 Mar-09 Jun-09 Sep-09 Dec-09 Mar-10 Jun-10 Sep-10 Dec-10 Mar-11 Jun-11 Sep-11 Dec-110%

20%

40%

60%

80%

100%

0

100

200

300

400

500

600

700

63% 61%66% 66%

69%63% 66%

71% 69% 72% 74%78%

73% 74%78%

83%

75%

Proportion # clinics

PROPORTION OF ALL HIV PATIENTS SCREENED FOR TB WHO SCREENED

POSITIVE, OCTOBER-DECEMBER 2011

Perc

ent o

f pat

ient

s


Patients Screened

Overall n=27464

Mozambique n=7964

South Africa n=7016

Nigeria n=114

Tanzania n=3525

Cote d'Ivoire n=783

Rwanda n=116

Kenya n=7946

-10%

0%

10%

20%

30%

16%

21% 20% 19%18%

10%9%

6%

Patients screened positive

PROPORTION OF ALL NEW HIV PATIENTS WITH A POSITIVE TB SCREEN WHO INITIATED

TB TREATMENT, OCTOBER-DECEMBER 2011

Perc

ent o

f pat

ient

s


Overall n=4299

Nigeria n=22 South Africa n=1416

Tanzania n=638

Kenya n=493 Mozambique n=1643

Cote d'Ivoire n=77

Rwanda n=100%

10%

20%

30%

40%

50%

60%

70%

29%

64%

47%

27%24%

16%

10% 10%

PROPORTION OF ALL NEW HIV CARE PATIENTS WHO INITIATED TB TREATMENT,


Source: ICAP URS February 2012Note: Although Ethiopia does not report other TB indicators, they do report diagnosis data and are therefore included in this graph. Data are only from clinics currently supported and reporting.

Perc

ent o

f pat

ient

s

New HIV care patients

Overall n=40229

South Africa n=8219

Tanzania n=3531

Ethiopia n=2796

Mozam-bique n=14687

Kenya n=9339


Rwanda n=117

Nigeria n=444

0%

10%

20%

10%

16%

14%

12%

9%8%

6%

3%

0%

INDICATORS FOR HIV TESTING IN TB

PATIENTSWhat: Collects information from ICAP-supported facilities on a quarterly basis

Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 16 collected indicators.

HIV TESTING IN TB CLINICS, AS OF DECEMBER 31, 2011




DR Congo 12 10

Ethiopia 85 83

Kenya 296 283

Lesotho 17 17

Mozambique 56 56

Nigeria 8 6

Rwanda 2 2

South Africa 92 85

TOTAL 584 556 (95%)

PROPORTION OF NEW TB PATIENTS WITH UNKNOWN HIV STATUS TESTED FOR HIV,


Perc

ent o

f pa

tient

s

New TB patients w/

unknown HIV status


Overall n=13973

Rwanda n=22

DR Congo n=468

Ethiopia n=2507

Kenya n=2498

Lesotho n=3119

South Africa

n=3411

Cote d'Ivoire

n=384

Nigeria n=41

Mozam-bique n=1523

0%

50%

100%

85%

100%

89% 88% 87% 86% 86% 84%78%

75%

PROPORTION OF NEW TB PATIENTS WITH UNKNOWN HIV STATUS AT ICAP-SUPPORTED TB

CLINICS TESTED FOR HIV OVER TIME

Perc

ent o

f pat

ient

s

Source: ICAP URS February 2012.

Dec-07

Mar-08

Jun-08

Sep-08

Dec-08

Mar-09

Jun-09

Sep-09

Dec-09

Mar-10

Jun-10

Sep-10

Dec-10

Mar-11

Jun-11

Sep-11

Dec-11

0%

50%

100%

0

100

200

300

400

500

600

88%83%

90% 90% 90% 92% 94%88% 89%

85%81%

78%85%

77%

85%88% 85%

Proportion # clinics

PROPORTION OF TB PATIENTS WHO TESTED HIV POSITIVE,

BY COUNTRY, OCTOBER-DECEMBER 2011

Perc

ent o

f pa

tient

s

New TB patients

tested for HIV

Source: ICAP URS February 2012. Note: In Nigeria, Ethiopia, Mozambique, Côte d’Ivoire, and Rwanda, the bar represents the proportion of new TB patients with an unknown HIV status who were HIV tested at the TB clinic upon enrollment. In Kenya , and South Africa, the bar represents those new TB patients who were HIV tested at any clinic.

Tested at any clinicTested at TB clinic

Overall n=11927

Mozam-bique n=1136

Nigeria n=32

Cote d'Ivoire

n=323

DR Congo n=416

Rwanda n=22

Ethiopia n=2207

Lesotho n=2687

South Africa

n=2938

Kenya n=2166

0%

20%

40%

60%

80%

43%

36%

16%11% 10%

5% 2%

76%

61%

34%

PROPORTION OF HIV(+) TB PATIENTS ENROLLING IN HIV CARE, OCTOBER-DECEMBER 2011

Perc

ent o

f pa

tient

s

New TB patients testing positive for HIV

Source: ICAP URS February 2012. Note: In Nigeria, Ethiopia, Mozambique, Côte d’Ivoire, Rwanda, the bar represents the proportion of new TB patients with an unknown HIV status who were HIV tested at the TB clinic upon enrollment. In Kenya, South Africa, and DR Congo, the bar represents those new TB patients who were HIV tested at any clinic.

Tested at any clinicTested at TB clinic

Overall n=3065

Rwanda n=1

Mozambique n=410

DR Congo n=41

Ethiopia n=50

Cote d'Ivoire n=34

Nigeria n=5

South Africa

n=1793

Kenya

n=731

0%

50%

100%

81%

100%

88%83% 80%

26%

0%

84%

73%

Indicators for HIV Testing and Counseling

What: Collects information from ICAP-supported facilities on a quarterly basis

Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 9 indicators.

COUNSELING AND TESTING,AS OF DECEMBER 31, 2011




DR Congo 23 14

Ethiopia 85 83

Kenya 218 195

Mozambique 108 104

Nigeria 56 32

Rwanda 5 5

South Africa 97 86

Tanzania 313 313

TOTAL 1021 932 (91%)

HIV TESTING AND COUNSELING, CUMULATIVE EXPERIENCE, AS OF DECEMBER 31, 2011

Source: ICAP URS February 2012Notes: Data are not available for all indicators in all points of service.

Num

ber o

f pat

ient

s

0

500,000

1,000,000

1,500,000

2,000,000

2,500,000

3,000,000

3,500,000

4,000,000

4,500,000

4,002,6243,983,199

100%

260,0086% 124,733

48%

Pre-test counseled and testedReceived test resultsHIV+ among all clients testedHIV+ and enrolled in care and treatment

NUMBER OF CLIENTS COUNSELED AND TESTED, RECEIVED RESULTS, AND ENROLLED

IN CARE AND TREATMENT, OVER FIVE MOST RECENT QUARTERS


Num

ber o

f pat

ient

s

Dec-10 Mar-11 Jun-11 Sep-11 Dec-110

100,000

200,000

300,000

400,000

500,000

600,000

469,040 505,931 504,902 528,815

529,479

29,114(6%)

35,110(7%)

31,757(6%)

30,223(6%)

34,476(6%) 13,909

(48%) 16,306(46%)

15,596(49%)

17,112(57%)

15,263(44%)

Tested and received results HIV+ HIV+ and enrolled in care and treatment

NUMBER OF CLIENTS COUNSELED AND TESTED, RECEIVED RESULTS, AND ENROLLED IN CARE AND TREATMENT, BY SEX, OVER FIVE

MOST RECENT QUARTERS


Num

ber o

f pat

ient

s

Sep-10 Dec-10 Mar-11 Jul-11 Sep-11

Female Male Female Male Female Male Female Male Female Male0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

259,215

210,398

284,859

221,237

290,533

224,327

287,930

222,844

303,030

235,068

18,297(7%) 10,817

(5%)

21,349(7%) 13,761

(6%)

19,458(7%) 12,299

(5%)

18,804(7%) 11,419

(5%)

21,528(7%) 12,948

(6%) 8,449(46%)

5,460(50%)

9,994(47%)

6,312(46%)

9,378(48%)

6,218(51%)

10,517(56%)

6,595(58%)

9,390(44%)

5,873(45%)

Counseled and tested HIV+ Enrolled in care and treatment

NUMBER OF CLIENTS COUNSELED AND TESTED, RECEIVED RESULTS, AND ENROLLED

IN CARE AND TREATMENT, BY AGE, OVER THREE MOST RECENT QUARTERS

Source: ICAP URS February 2012Notes: Sites which are not able to specify patient age are excluded.

Num

ber o

f pat

ient

s

Mar-11 Jun-11 Sep-11

Adults Children Unknown Adults Children Unknown Adults Children Unknown0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

450,000

394,046

82,185

38,629

399,534

75,352

35,888

414,243

82,270

41,585 18,862(5%) 1,340

(2%)

11,555(30%)

19,512(5%) 1,345

(2%) 9,366(26%)

21,8575%) 1,425

2%)

11,194(27%)

12,66167%) 701

(52%) 2,234(19%)

13,64770%) 660

(49%) 2,805(30%)

11,739(54%) 547

(38%) 2,977(27%)

Counseled and testedHIV+Enrolled in care and treatment

Num

ber o

f pat

ient

s

Source: ICAP URS February 2012Note: *Most data from VCT clinics comes from Ethiopia, which may decrease the overall % positive found in VCT clinics; **Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other.

NUMBER OF ADULT AND PEDIATRIC PATIENTS COUNSELED AND TESTED, BY POINT OF

SERVICE, OCTOBER-DECEMBER 2011

Outpatient VCT* Other** Inpatient All points of service Outreach0

50,000

100,000

150,000

200,000

250,000

300,000

350,000

312,039

91,569

56,433 45,060

27,140

5,857 10,535(3%)

12,553(14%) 4,302

(8%) 1,790 (4%)

5,255 (19%)

41(1%)

2,552*24%)

6,362(51%)

1,022(24%)

592(33%)

4,724(90%)

11(27%)

Counseled and tested HIV+

Enrolled in care and treatment

Source: ICAP URS February 2012 Note: * Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics; ** Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other.

NUMBER OF ADULT PATIENTS COUNSELED AND TESTED, BY POINT OF SERVICE,


Num

ber o

f pat

ient

s

Outpatient VCT* Other** Inpatient All points of service Outreach0

50,000

100,000

150,000

200,000

250,000

300,000

250,345

63,690

37,530 32,065 25,660

4,953 9,707(4%)

4,465 (7%)

935(2%)

1,562(5%)

5,150 (20%)

38(1%)

2,392( 25%)

3,620(81%)

581(62%)

500(32%)

4,637(90%)

9(24%)



Source: ICAP URS February 2012 Note: *Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics; **Other includes: laboratory, family planning, well baby clinic, casualty/trauma, palliative care/hospice, customer care, cervical cancer screening, STI clinic, HIV care / ART (family testing), TB clinic, blood donation center, PITC (all), and other .

NUMBER OF PEDIATRIC PATIENTS COUNSELED AND TESTED, BY POINT OF

SERVICE, OCTOBER-DECEMBER 2011

Num

ber o

f pat

ient

s

Outpatient Inpatient VCT* Other** All points of service Outreach0

10,000

20,000

30,000

40,000

50,000

60,000

70,000

61,694

12,995

3,422 1,775 1,480 904

828(1%)

228(2%)

214(6%)

47(3%)

105(7%)

3(0.3%)

160(19%)

92(40%)

175(82%)

31(66%)

87(83%)

2 (67%)



Source: ICAP URS February 2012Notes: Excludes pregnant women tested as part of PMTCT.

NUMBER OF PATIENTS RECEIVING PRE-TEST COUNSELING AND TESTING, BY COUNTRY,


Num

ber o

f pat

ient

s

Number of facilities

Cote d'Ivoire

n= 100

DR Congo n= 14

Ethiopia n= 83

Kenya n= 195

Mozam-bique

n= 104

Nigeria n= 32

Rwanda n= 5

South Africa

n= 86

Tanzania n= 313

0

50,000

100,000

150,000

200,000

250,000

300,000

15,908462

259,204

126,414

41,585

2,792 2,839

31,757

60,687


PERCENT OF PATIENTS WHO WERE HIV+, BY COUNTRY,


Perc

ent o

f pat

ient

s

Cote d'Ivoire DR Congo Ethiopia Kenya Mozambique Nigeria Rwanda South Africa Tanzania0%

10%

20%

30%

40%

9%11%

2%

6%

32%

22%

2%

20%

7%9%

6%

1%

7%

27%

18%

6%

20%

7%

Mean Oct 2009 - Oct 2011 % Positive Oct-Dec 2011

Source: ICAP URS February 2012. Note: Kenya, Rwanda, and Nigeria do not currently report enrollment or referral to HIV care data.

PERCENT OF POSITIVE PATIENTS ENROLLED INTO CARE AND TREATMENT, BY COUNTRY,


Num

ber o

f pat

ient

s

Mozambique n= 3398

Tanzania n= 3830

Ethiopia n= 2847

DR Congo n= 29

Cote d'Ivoire n= 1359

South Africa n= 6223

0%

20%

40%

60%

80%

100%

88% 85%77%

48%41%

96%

Indicators for Clinical Laboratories

What: Collects information from ICAP-supported facilities on a quarterly basis

Purpose: To describe quarterly and cumulative progress towards targets and overall achievements through 2 indicators.

LABORATORYAS OF DECEMBER 31, 2011




DR Congo 6 .

Ethiopia 88 .

Kenya 209 202

Mozambique 54 53

Nigeria 8 .

Rwanda 6 4

South Africa . .

Tanzania 111 91

TOTAL 500 367 (73%)

PROPORTION OF CARE AND TREATMENT FACILITIES WITH

CLINICAL LABORATORIES, OCTOBER-DECEMBER 2011

Perc

ent o

f fac

ilitie

s wi

th c

linica

l labo

rato

ries

Source: ICAP Site Census June 2011.

Number of care and treatment facilities

0%

20%

40%

60%

80%

100%100% 100%

79%73% 72%

31% 28%

15%

Num

ber o

f tes

ts

HIV-RELATED TESTS CONDUCTED BY COUNTRY,


Source: ICAP URS February 2012Note: Nigeria did not report PCR, viral load, or EIA. Ethiopia did not report any lab tests, but they do support laboratory services.

Cote d'Ivoire Kenya Mozambique Rwanda Tanzania0

10,000

20,000

30,000

40,000

50,000

60,000

70,000

80,000

HIV simple rapid CD4 count CD4 % AFBViral load PCR EIA

For more information, please see:

• ICAP URS

• ICAP Data Dissemination Page

• PFACTS Country Reports

http://www.mericap.columbia.edu/

http://www.socialtext.net/icap_data_dissemination/index.cgi?icap_data_dissemination

http://www.socialtext.net/icap_data_dissemination/index.cgi?icap_data_dissemination

icap m&e master slide deck data through december 31, 2011

Documents

treatment facilities

comprehensiveness of

icap staff

closed icap facilities

icap pfacts round

icap site census

treatment clinics

servicesproportion of